Lantern Pharma Inc. (LTRN) Form 10-Q Quarterly Reports
Lantern Pharma Inc. (LTRN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LTRN
CIK: 1763950
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: TX
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerJoseph DiFalco
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-006874 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-08 | 2026-10-08 | PRE 14A | 0001493152-26-046325 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-25 | 8-K | 0001493152-26-045344 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-28 | 8-K | 0001493152-26-045100 | View SEC Doc Filr Page |
| 424B5 | 2026-09-30 | — | 424B5 | 0001493152-26-045049 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-23 | 8-K | 0001493152-26-044007 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001493152-26-043808 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001493152-26-037979 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-037971 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0000919574-26-004747 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001493152-26-035864 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-23 | — | SCHEDULE 13G/A Filing | 0001104659-26-086180 | View SEC Doc Filr Page |
| EFFECT | 2026-06-18 | — | EFFECT Filing | 9999999995-26-002072 | View SEC Doc Filr Page |
| S-1 | 2026-06-12 | — | S-1 | 0001493152-26-028460 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-01 | 8-K | 0001493152-26-026696 | View SEC Doc Filr Page |
| D | 2026-05-21 | — | D Filing | 0001493152-26-024786 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-15 | — | SCHEDULE 13D/A Filing | 0001813314-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001493152-26-023758 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023740 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-12 | 8-K | 0001493152-26-023200 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | 4 | 0001493152-26-023083 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | 4 | 0001493152-26-023082 | View SEC Doc Filr Page |
| 424B5 | 2026-05-14 | — | 424B5 | 0001493152-26-022895 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001493152-26-019713 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-16 | — | SCHEDULE 13D/A Filing | 0001813314-26-000005 | View SEC Doc Filr Page |